Notch pathway activation induces neuroblastoma tumor cell growth arrest

Pediatric Blood and Cancer

Volumn 58, Issue 5, 2012, Pages 682-689

  Zage, Peter E ^a,b,c   Nolo, Riitta ^a   Fang, Wendy ^a   Stewart, John ^a   Garcia Manero, Guillermo ^a   Zweidler Mckay, Patrick A ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

HES; ICN; Neuroblastoma; Notch

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CONSTRUCT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN METHYLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; HOMEODOMAIN PROTEINS; HUMANS; NEUROBLASTOMA; PROMOTER REGIONS, GENETIC; RECEPTORS, NOTCH; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84857885769     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23202     Document Type: Article

References (41)

1. Ladenstein R, Philip T, Lasset C, et al. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year Treated with megatherapy and stem-cell transplantation: A report from the European bone marrow transplantation solid tumor registry. J Clin Oncol 1998; 16: 953-965.
2. Matthay KK, Reynolds CP, Seeger RC, et al. Long-Term Results for Children with High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study. J Clin Oncol 2009; 27: 1007-1013.
3. Zage PE, Kletzel M, Murray K, et al. Outcomes of the POG 9340/9341/9342 trial for children with high-risk neuroblastoma: A report from the Children's Oncology Group. Pediatr Blood Cancer 2008; 51: 747-753.
4. Iso T, Kedes L, Hamamori Y. HES and HERP families: Multiple effectors of the notch signaling pathway. J Cell Physiol 2003; 194: 237-255.
5. Nagao M, Sugimori M, Nakafuku M. Cross talk between notch and growth factor/cytokine signaling pathways in neural stem cells. Mol Cell Biol 2007; 27: 3982-3994.
6. Leong KG, Karsan A. Recent insights into the role of notch signaling in tumorigenesis. Blood 2006; 107: 2223-2233.
7. Zweidler-McKay PA. Notch signaling in pediatric malignancies. Curr Oncol Rep 2008; 10: 459-468.
8. Grynfeld A, Pahlman S, Axelson H. Induced neuroblastoma cell differentiation, associated with transient Hes-1 activity and reduced HASH-1 expression, is inhibited by notch. Int J Cancer 2000; 88: 401-410.
9. Hooper C, Tavassoli M, Chapple JP, et al. TAp73 isoforms antagonize notch signalling in SH-SY5Y neuroblastomas and in primary neurones. J Neurochem 2006; 99: 989-999.
10. Liao Y-F, Wang B-J, Hsu W-M, et al. Unnatural amino acid-substituted (hydroxyethyl) urea peptidomimetics inhibit g-secretase and promote the neuronal differentiation of neuroblastoma cells. Mol Pharmacol 2007; 71: 588-601.
11. Chang H-H, Lee H, Hu M-K, et al. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res 2010; 16: 4411-4420.
12. Jogi A, Persson P, Grynfeld A, et al. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J Biol Chem 2002; 277: 9118-9126.
13. van Limpt VAE, Chan AJ, van Sluis PG, et al. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int J Cancer 2003; 105: 61-69.
14. Stockhausen M-T, Sjolund J, Manetopoulos C, et al. Effects of the histone deacetylase inhibitor valproic acid on notch signalling in human neuroblastoma cells. Br J Cancer 2005; 92: 751-759.
15. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973; 33: 2643-2652.
16. Brodeur GM, Green AA, Hayes FA, et al. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 1981; 41: 4678-4686.
17. Reynolds CP, Tomayko MM, Donner L, et al. Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res 1988; 2: 291-306.
18. Foley J, Cohn SL, Salwen HR, et al. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell lines. Cancer Res 1991; 51: 6338-6345.
19. Hansford LM, McKee AE, Zhang L, et al. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 2007; 67: 11234-11243.
20. Zhang P, Yang Y, Zweidler-McKay PA, et al. Critical Role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008; 14: 2962-2969.
21. Zweidler-McKay PA, He Y, Xu L, et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 2005; 106: 3898-3906 (see Supporting Material for this reference).
22. Zage PE, Zeng L, Palla S, et al. A novel therapeutic combination for neuroblastoma: The VEGFR/EGFR/RET inhibitor vandetanib with 13-cis-retinoic acid. Cancer 2010; 116: 2465-2475.
23. Sahlgren C, Gustafsson MV, Jin S, et al. Notch Signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 2008; 105: 6392-6397.
24. Hughes DPM, Thomas DG, Giordano TJ, et al. Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma. Cancer Res 2004; 64: 2047-2053.
25. Garcia-Manero G, Bueso-Ramos C, Daniel J, et al. DNA methylation patterns at relapse in adult acute lymphocytic leukemia. Clin Cancer Res 2002; 8: 1897-1903.
26. Mosse YP, Greshock J, Margolin A, et al. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 2005; 43: 390-403.
27. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: Cell fate control and signal integration in development. Science 1999; 284: 770-776.
28. Morrison SJ, Perez SE, Qiao Z, et al. Transient notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 2000; 101: 499-510.
29. Cornell RA, Eisen JS. Notch in the pathway: The roles of notch signaling in neural crest development. Semin Cell Dev Biol 2005; 16: 663-672.
30. Ohtsuka T, Ishibashi M, Gradwohl G, et al. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J 1999; 18: 2196-2207.
31. Gaiano N, Fishell G. The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci 2002; 25: 471-490.
32. Kabos P, Kabosova A, Neuman T. Blocking HES1 expression initiates GABAergic differentiation and induces the expression of p21(CIP1/WAF1) in human neural stem cells. J Biol Chem 2002; 277: 8763-8766.
33. Basak O, Taylor V. Identification of self-replicating multipotent progenitors in the embryonic nervous system by high notch activity and Hes5 expression. Eur J Neurosci 2007; 25: 1006-1022.
34. Hatakeyama J, Bessho Y, Katoh K, et al. Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development 2004; 131: 5539-5550.
35. Fan X, Mikolaenko I, Elhassan I, et al. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 2004; 64: 7787-7793.
36. Ferrari-Toninelli G, Bonini SA, Uberti D, et al. Targeting notch pathway induces growth inhibition and differentiation of neuroblastoma cells. Neuro-Oncology 2010.
37. Funahashi Y, Hernandez SL, Das I, et al. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res 2008; 68: 4727-4735.
38. Kageyama R, Ohtsuka T, Hatakeyama J, et al. Roles of bHLH genes in neural stem cell differentiation. Exp Cell Res 2005; 306: 343-348.
39. Attiyeh AF, London WB, Mossé YP, et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 2005; 353: 2243-2253.
40. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999; 17: 2264-2279.
41. White PS, Thompson PM, Gotoh T, et al. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 2005; 24: 2684-2694.